Home
>
National Drug Code (NDC)
>
Ceftriaxone
Ceftriaxone - 10019-098-01 - (Ceftriaxone Sodium)
Drug Information of Ceftriaxone
| Product NDC: | 10019-098 |
| Proprietary Name: | Ceftriaxone |
| Non Proprietary Name: | Ceftriaxone Sodium |
| Active Ingredient(s): | 1 g/1 & nbsp; Ceftriaxone Sodium |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ceftriaxone
| Product NDC: | 10019-098 |
| Labeler Name: | BAXTER HEALTHCARE CORPORATION |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065125 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030930 |
Package Information of Ceftriaxone
| Package NDC: | 10019-098-01 |
| Package Description: | 10 VIAL in 1 BOX (10019-098-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (10019-098-71) |
NDC Information of Ceftriaxone
| NDC Code | 10019-098-01 |
| Proprietary Name | Ceftriaxone |
| Package Description | 10 VIAL in 1 BOX (10019-098-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (10019-098-71) |
| Product NDC | 10019-098 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ceftriaxone Sodium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20030930 |
| Marketing Category Name | ANDA |
| Labeler Name | BAXTER HEALTHCARE CORPORATION |
| Substance Name | CEFTRIAXONE SODIUM |
| Strength Number | 1 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |
